Optimization of the Targeted Anticancer Therapies

Recruiting now · Not applicable

Conditions studied: Cancer

In brief

The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (observational study) and 2) to characterize patterns of adherence to oral targeted anticancer drugs and identify key-driver modifiable adherence factors in patients participating in an adherence program (interventional study).

Key facts

Study ID

NCT04484064

Run by

Centre Hospitalier Universitaire Vaudois

People needed

500

Starts

2015-05-01

Expected to finish

2030-12-01

Last updated by the study team

2020-07-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cancer patients to whom a targeted anticancer therapy is prescribed

You may not qualify if…

• Patients incapable of judgment or participants under tutelage

Where it is running

• CHUV — Lausanne, Canton of Vaud, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.